American College of Cardiology 2017 Preview The Cardiology Advisor (registration) The 2017 American College of Cardiology (ACC) 66th Scientific Session & Expo will take place from Friday, March 17, through Sunday, March 19, in Washington, DC. This year, the ACC accepted 23 late-breaking clinical trials, 17 of which were accepted as ... See the original post here: American College of Cardiology 2017 Preview - The Cardiology Advisor (registration) … Continue reading →

Updated 2 minutes ago A Connecticut cardiologist testified Wednesday that as many as five stents implanted into a North Huntingdon truck driver in late 2008 were unnecessary and led to complications that nearly cost Steven Sensenich his life. During the third day in a malpractice trial, Dr. John Setaro told jurors that medical evidence did not support the decision by Dr. Ehab Morcos to perform two separate procedures at Excela Health Westmoreland Hospital. There was no need for more invasive procedures as there were no (health) indications and no benefits, Setaro said. A Westmoreland County jury is hearing evidence in lawsuit brought by Sensenich against Morcos, Westmoreland County Cardiology, his cardiac practice, and Excela that alleges unnecessary medical procedures. The trial is the first of 71 cases pending against Excela, Morcos and Dr. George Bou Samra that were filed after the hospital issued 192 disclosures to patients who were suspected to have received unnecessary stents from the doctors in 2009 and 2010. Sensenich was not part of that disclosure, but he contends Morcos recommended and performed three procedures to implant unneeded stents, mesh tubes that increase blood flow in cardiac arteries. Setaro reviewed Sensenich's medical records and narrated to jurors … Continue reading →

As the population ages, we continue to see more patients diagnosed with atrial fibrillation. Some are even calling the increase in atrial fibrillation diagnoses an epidemic. Frequently, these patients require chronic oral anticoagulation. For decades, we have use vitamin K antagonists such as warfarin. Due to complex monitoring and dosage adjustments, drug interactions and potential side effects such as hemorrhagic stroke and gastrointestinal bleeding, patients and providers have always hoped an alternative to warfarin would come along. Over the last few years, a multitude of target specific oral anticoagulants (TSOACs) for treatment of nonvalvular atrial fibrillation have been approved. These new medications range from direct thrombin inhibitors to Factor Xa inhibitors. TSOACs are not without their drawbacks (bleeding, lack of a specific antidote for some), but for many, they are a significant advance over warfarin. To aid providers caring for patients on anti-platelet and anticoagulants, the American College of Cardiology (ACC) has been producing some outstanding apps. Previously on iMedicalApps we reviewed their outstanding Anticoag Evaluator and DAPT calculator apps. An additional resource is the excellent MAQI2 Anticoagulation Toolkit from the University of Michigan and insurer Blue Cross Blue Shield. How should providers handle patients with nonvalvular atrial fibrillation on … Continue reading →

NEW YORK, March 6, 2017 /PRNewswire/ -- Interventional cardiology specifically deals with the catheter based treatment of cardiovascular and structural heart diseases. Products of interventional cardiology market are Catheters, Interventional Diagnostic Catheters, stents, valves, transcatheter heart pump and others. Catheters are segmented into Guide Catheter, Balloon Catheter, Atherectomy Catheters, Thrombectomy Catheters, and Ablation Catheters. Read the full report: http://www.reportlinker.com/p04756645-summary/view-report.html Interventional Diagnostic Catheters are segmented into Intravascular ultrasound (IVUS), Fractional flow reserve (FFR), Optical coherence tomography (OCT), Angiograph, Pulmonary artery catheter, Electrophysiology catheter. Stents are further categorised into bare metal stents, drug eluting stents, Bioresorbable stents and Stent grafts. Valves are further divided into Transcatheter Aortic Valve, Annuloplasty Ring, Mitral Clip, and Valvuloplasty. Others are segmented into closure devices (Occluders), Inferior vena cava filters, Guide wires, Transcatheter pacemaker, and accessories. Applications of Interventional cardiology market are segmented into Diagnostic catheterization, Coronary Interventions, Peripheral interventions and Structural Heart. Coronary intervention application is sub-segmented into Aortic aneurysm (EAVR, TEVAR), Coronary Thrombectomy, PCTA, Coronary Cardiac Ablation and others. Peripheral interventions are sub-segmented into Peripheral Aneurysm, Peripheral Thrombectomy, Peripheral Angioplasty, Peripheral Ablation, Pulmonary embolism, and others. Structural heart is further sub-segmented into Valve replacement, Valve repair, Heart Assist Device, Congenital heart defect and others. The … Continue reading →